An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Evolus, Inc. (NASDAQ: EOLS), a company focused on beauty products, is participating in two investment conferences in November 2022. The first event is the Stifel 2022 Healthcare Conference on November 15, 2022, from 8:35-9:05 am ET. The second event is the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022, from 11:45-12:05 pm ET. Audio webcasts of both events will be available on Evolus’ investor relations website, with replays accessible for 90 days.
Positive
None.
Negative
None.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in two investment conferences in November.
Event:
Stifel 2022 Healthcare Conference
Date:
Tuesday, November 15, 2022
Time:
8:35-9:05 am ET
Event:
5th Annual Evercore ISI HealthCONx Conference
Date:
Wednesday, November 30, 2022
Time:
11:45-12:05 pm ET
Audio webcasts of these events will be available on the investor relations section of Evolus’ website at www.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Visit us at www.evolus.com and follow us on LinkedIn, Twitter, Instagram or Facebook.
Jeuveau® is a registered trademark of Evolus, Inc. Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Investor/Media Contact:
David K. Erickson, Evolus, Inc. Vice President, Investor Relations
Tel: 949-966-1798
Email: david.erickson@evolus.com
Source: Evolus
FAQ
What events will Evolus, Inc. participate in during November 2022?
Evolus will participate in the Stifel 2022 Healthcare Conference on November 15, 2022, and the 5th Annual Evercore ISI HealthCONx Conference on November 30, 2022.
When is the Stifel 2022 Healthcare Conference featuring Evolus, Inc.?
The Stifel 2022 Healthcare Conference is on November 15, 2022, from 8:35 to 9:05 am ET.
What time will Evolus present at the Evercore ISI HealthCONx Conference?
Evolus will present at the Evercore ISI HealthCONx Conference on November 30, 2022, from 11:45 am to 12:05 pm ET.
Where can I find the webcasts for Evolus' conference presentations?
The audio webcasts for Evolus' conference presentations will be available on their investor relations website.
How long will the conference webcasts for Evolus be available for replay?
The conference webcasts will be available for replay for 90 days after the presentations.